| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |